Provenge is one of the best alternative treatment options for prostate cancer

Mechanism of action of Provenge

What can be the best option for treatment of Cancer than an Alternative Cancer Treatment especially, if it is a highly recommended medicine for the treatment of a cancer?

Prostate Cancer Ribbon[hana-code-insert name=’StumbleUpon’ /][hana-code-insert name=’Reddit’ /]Sipuleucel-T (APC8015, trade name Provenge) is a therapeutic cancer vaccine for advanced prostate cancer. It has been manufactured by Dendreon Corporation and approved by U.S. Food and Drug Administration (FDA) in 2010.

Provenge is neither chemotherapy nor a form of hormone therapy. It is immunotherapy that causes the immune system of the patients to fight against cancer.

Each dose of the medicine has to be prepared specifically for each patient using his own immune cells, i.e. white blood cells (WBCs). In the treatment, WBCs of the patient are collected, activated to seek and attack prostate cancer cells and again introduced into the patient’s blood circulation to do their task.  Typical treatment is completed within a month.

It has extended survival time and is superior to any other treatment for advanced prostate cancer.

According to the reports, the company would see huge gains on this medicine by 2013.

Recently, Fort Wayne Medical Oncology and Hematology (FWMOH) has announced that the institute is going to offer Provenge for the treatment of advanced prostate cancer.

“We’re very pleased to continue to be on the leading edge of cancer treatment with this radical new approach to treating prostate cancer,” says Dan Konow, chief operating officer for Fort Wayne Medical Oncology and Hematology.

According to American Cancer Society, prostate cancer is the second most common cancer in American men after skin cancer.

saypeople

SayPeople.com gives you the news and information about Science, Research, Technology, Business and Islam.

%d bloggers like this: